Weintraub Bennett has filed 3 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 10000 shares of Apimeds Pharmaceuticals US, Inc. ($APUS) on November 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 11, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Weintraub Bennett | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 12,575,983 | 9999.99% | 0.08% |
| Oct. 15, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Weintraub Bennett | Director | A | Stock Option (right to buy) | 3000 | $0.00 | 3,000.0000 | 12,575,983 | 9999.99% | 0.02% |
| May 16, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Weintraub Bennett | Director | A | Stock Option (right to buy) | 5780 | $0.00 | 5,780.0000 | 7,903,850 | 9999.99% | 0.07% |